Available with corporate subscription
On 29 September 2017, Drylet announced a successful trial with California Water Services Group to utilize the Texas-based firm’s biocatalyst technology to reduce sludge and associated biosolid management costs. Drylet’s biocatalysts are designed to accelerate biological processes at wastewater treatment plants to reduce produced biosolids by up to 50%.
A key business driver to this pilot, and recently announced partnership, is Cal Water’s rising OPEX, as utilities strive to capitalize on efficiencies and mitigate ratepayer pushback.
In this Research Note, Bluefield water experts analyze the reasons behind this partnership, examining Drylet’s business model and alternatives to biosolids.
